FOX 9 Minneapolis-St. Paul on MSN1h
Cigna sues, wants leeway to tell customers which pharmacies to useA giant healthcare company is suing the State of Minnesota over a state law that is supposed to protect small pharmacies in ...
Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies, with ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Hosted on MSN3d
Report: Generic prescriptions marked up 5,000%A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
Pharmacists in the Four-States say their livelihoods are at risk as major companies gain more control of the drug market. They're warning that Pharmacy Benefit Mangers, better known as PBMs, have an ...
Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...
Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.
The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback